Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy

Record identifier

TN_cdi_plos_journals_2037055491

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2037055491

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy

Full title

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy

Publisher

United States: Public Library of Science

Journal title

PloS one, 2018, Vol.13 (5), p.e0196395-e0196395

Record Identifier

TN_cdi_plos_journals_2037055491

Language

English

Formats

Publication information

Publisher

Subjects

Subjects and topics

Adipocytes Adiponectin Adiponectin - blood Adiponectin - metabolism Adiponectin - pharmacology Adiponectin - therapeutic use Adipose tissue Adult Amino Acid Oxidoreductases - analysis Amino Acid Oxidoreductases - blood Anti-HIV Agents - therapeutic use Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiviral agents Bioindicators Biology and Life Sciences Biomarkers Biomarkers - blood Body mass Cardiovascular disease CD4 antigen CD4 Lymphocyte Count Cell number Chitinase Chitinase-3-Like Protein 1 - drug effects Chitinase-3-Like Protein 1 - metabolism Complications and side effects Correlation Cryopreservation Diabetes Dosage and administration Drug therapy Enzyme-linked immunosorbent assay Extracellular matrix Fatty liver Fatty Liver - drug therapy Fatty Liver - metabolism Female Fibrosis Growth factors HIV HIV infection HIV Infections - drug therapy HIV Protease Inhibitors - therapeutic use Human immunodeficiency virus Humans Hyaluronic acid Infections Infectious diseases Inflammation Insulin resistance Internal medicine Liver Liver diseases Lymphocytes T Lysyl oxidase Medicine and Health Sciences Metabolic disorders Metabolic Syndrome - metabolism Metabolic syndrome X Metabolism Metalloproteinase Middle Aged Mortality Non-nucleoside reverse transcriptase inhibitors Nucleoside reverse transcriptase inhibitors Obesity Obesity - physiopathology Patient outcomes Prospective Studies Raltegravir Raltegravir Potassium - metabolism Raltegravir Potassium - pharmacology Raltegravir Potassium - therapeutic use Randomization Regression analysis Regression models Reverse Transcriptase Inhibitors - pharmacology Reverse Transcriptase Inhibitors - therapeutic use Risk factors RNA-directed DNA polymerase Steatosis Switching Therapy Tissue inhibitor of metalloproteinase 1 Tissue Inhibitor of Metalloproteinase-1 - analysis Tissue Inhibitor of Metalloproteinase-1 - blood Transforming growth factor Transforming growth factor-b Viral Load

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_plos_journals_2037055491

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2037055491

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card